🔎 Trials Near Me

Hjem › Melanom › Florida › Orlando

Melanom kliniske forsøg i Orlando, FL

15 studier for Melanom søger deltagere på steder i og omkring Orlando (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

RekruttererFase 2
  • AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · 16 mi væk
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06172478

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

RekruttererFase 3
  • Orlando Health Cancer Institute, Orlando
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT05727904

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

RekruttererFase 2
  • Nemours Children's Hospital, Orlando
Op til 25 år · Alle køn · Opdateret 24. sep. 2026 · NCT07621614

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

RekruttererFase 3
  • Orlando Health Cancer Institute, Orlando
  • Health Central, Ocoee · 10 mi væk
Alder 75 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07068074

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

RekruttererFase 1
  • AdventHealth, Orlando
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT06529822

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

RekruttererFase 2
  • Orlando Health Cancer Institute, Orlando
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04511013

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

RekruttererFase 1
  • Sarah Cannon Research Institute - Florida Cancer Specialists, Orlando
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT04913285

Project: Every Child for Younger Patients With Cancer

RekruttererObservationsstudie
  • AdventHealth Orlando, Orlando
  • Arnold Palmer Hospital for Children, Orlando
  • Nemours Children's Hospital, Orlando
Op til 25 år · Alle køn · Opdateret 25. aug. 2026 · NCT02402244

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

RekruttererFase 1/2
  • AdventHealth Celebration, Celebration · 17 mi væk
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT05592626

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

RekruttererFase 1/2
  • Clermont Oncology Center, Clermont · 24 mi væk
Alder 18 og opefter · Alle køn · Opdateret 29. jul. 2026 · NCT04198766

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

RekruttererFase 1
  • Florida Cancer Specialists - Lake Nona, Orlando
Alder 18 og opefter · Alle køn · Opdateret 28. jul. 2026 · NCT06150664

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

RekruttererFase 1/2
  • Orlando Health Cancer Institute (Melanoma/NSCLC), Orlando
Alder 18 og opefter · Alle køn · Opdateret 16. jul. 2026 · NCT06060613

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

RekruttererFase 1/2
  • Orlando Health Cancer Institute, Orlando
Alder 18 til 70 · Alle køn · Opdateret 11. jun. 2026 · NCT05361174

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

RekruttererFase 3
  • Orlando Health Cancer Institute, Orlando
Alder 18 og opefter · Alle køn · Opdateret 25. feb. 2026 · NCT05549297

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

RekruttererFase 1/2
  • Research Site 137, Orlando
  • Research Site 118, Celebration · 17 mi væk
Alder 18 og opefter · Alle køn · Opdateret 21. nov. 2025 · NCT05914116

Melanom forsøg i andre byer

Andre studier i Orlando

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.